What is the recommended approach for preventing clotting in dialysis lines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the FDA Drug Label

A dose of 25 to 30 units/kg followed by an infusion rate of 1,500 to 2,000 units/hour is suggested based on pharmacodynamic data if specific manufacturers' recommendations are not available. The recommended approach for preventing clotting in dialysis lines, specifically for extracorporeal dialysis, is to administer heparin at a dose of 25 to 30 units/kg followed by an infusion rate of 1,500 to 2,000 units/hour 1.

  • Key points:
    • Initial dose: 25 to 30 units/kg
    • Infusion rate: 1,500 to 2,000 units/hour
  • This approach is based on pharmacodynamic data and is suggested when specific manufacturers' recommendations are not available.

From the Research

The recommended approach for preventing clotting in dialysis lines is to use heparin 1000 U/ml or 4% sodium citrate as a lock solution, as these concentrations have been shown to maintain patency of tunneled central venous catheters for dialysis while minimizing the risk of systemic anticoagulation 2. The use of heparin as a lock solution is a common practice in dialysis, and the concentration of 1000 U/ml has been found to be effective in preventing catheter malfunction while reducing the risk of bleeding complications.

  • The study by 2 found that heparin 1000 U/ml and 4% sodium citrate are suitable choices for lock solution to maintain patency of tunneled central venous catheters for dialysis.
  • Another study by 3 compared the effectiveness of two heparin concentrations (10,000 and 1,000 U/mL) in preventing catheter malfunction and found that the use of a lower concentration of heparin was not associated with an increased risk of catheter malfunction.
  • However, it is essential to note that the use of tissue plasminogen activator (t-PA) as a locking solution may also be effective in preventing clotting, as shown in the study by 4, which found that t-PA 2 mg preserved dialysis catheter performance and did not cause any bleeding or catheter thrombosis.
  • In terms of the Davita protocol, the most recent and highest quality study 2 suggests that heparin 1000 U/ml or 4% sodium citrate should be used as a lock solution to prevent clotting in dialysis lines, rather than relying on a specific protocol.
  • The study by 5 also found that continuous saline infusion (CSI) may be a better method of preventing the extracorporeal circuit from clotting when heparin-free dialysis is indicated, but this is not directly related to the use of heparin or citrate as a lock solution.

References

Research

Concentration of heparin-locking solution and risk of central venous hemodialysis catheter malfunction.

ASAIO journal (American Society for Artificial Internal Organs : 1992), 2007

Research

Tissue plasminogen activator as a hemodialysis catheter locking solution.

Hemodialysis international. International Symposium on Home Hemodialysis, 2008

Related Questions

What is the significance of a normal fibrinogen level, elevated D-dimer (2.07), normal prothrombin time (PT), normal international normalized ratio (INR), normal activated partial thromboplastin time (aPTT), and normal platelet count (179) in the setting of recurrent clotting of a hemodialysis catheter?
What is the preparation of heparinized (Heparin) saline solution?
What is the recommended protocol for maintaining patency of a port-a-cath (peripherally inserted central catheter) using heparin lock flush solution?
Is a heparin lock necessary for a Peripherally Inserted Central Catheter (PICC) line?
Is heparin present in a deaccessed port?
What is the initial treatment approach for patients with Rheumatoid Arthritis (RA) interstitial lung disease?
What are the diagnostic criteria and treatment for compartment syndrome?
What is the standard protocol for preventing clotting in dialysis lines, particularly in the context of Davita (Dialysis and Vascular Intervention Therapy) protocols, using heparin (unfractionated heparin)?
What is the recommended treatment for a postpartum patient with pulmonary embolism (PE)?
What is the recommended management of diuretic therapy in patients with acute kidney injury, specifically regarding the use of hydrochlorothiazide (HCTZ) versus loop diuretics like furosemide?
What is the management approach for a patient with inability to breathe when coughing and a large gastric bubble on chest X-ray, with symptoms suggestive of Irritable Bowel Syndrome (IBS) and potential Gastroesophageal Reflux Disease (GERD)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.